163 related articles for article (PubMed ID: 23593581)
21. Effect of combination of ketanserin and escitalopram on behavioral anomalies after olfactory bulbectomy: prediction of quick onset of antidepressant action.
Pandey DK; Bhatt S; Jindal A; Gautam B
Indian J Pharmacol; 2014; 46(6):639-43. PubMed ID: 25538337
[TBL] [Abstract][Full Text] [Related]
22. Rhodioloside ameliorates depressive behavior via up-regulation of monoaminergic system activity and anti-inflammatory effect in olfactory bulbectomized rats.
Zhang X; Du Q; Liu C; Yang Y; Wang J; Duan S; Duan J
Int Immunopharmacol; 2016 Jul; 36():300-304. PubMed ID: 27214337
[TBL] [Abstract][Full Text] [Related]
23. Acute ghrelin administration reverses depressive-like behavior induced by bilateral olfactory bulbectomy in mice.
Carlini VP; Machado DG; Buteler F; Ghersi M; Ponzio MF; Martini AC; Schiöth HB; de Cuneo MF; Rodrigues AL; de Barioglio SR
Peptides; 2012 Jun; 35(2):160-5. PubMed ID: 22525660
[TBL] [Abstract][Full Text] [Related]
24. Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression.
Vieyra-Reyes P; Mineur YS; Picciotto MR; Túnez I; Vidaltamayo R; Drucker-Colín R
Brain Res Bull; 2008 Sep; 77(1):13-8. PubMed ID: 18582540
[TBL] [Abstract][Full Text] [Related]
25. Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression.
Rinwa P; Kumar A; Garg S
PLoS One; 2013; 8(4):e61052. PubMed ID: 23613781
[TBL] [Abstract][Full Text] [Related]
26. Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.
Rodríguez-Gaztelumendi A; Rojo ML; Pazos A; Díaz A
J Neurochem; 2009 Mar; 108(6):1423-33. PubMed ID: 19183263
[TBL] [Abstract][Full Text] [Related]
27. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment.
Cryan JF; Page ME; Lucki I
Psychopharmacology (Berl); 2005 Nov; 182(3):335-44. PubMed ID: 16001105
[TBL] [Abstract][Full Text] [Related]
28. Acute administration of fluoxetine normalizes rapid eye movement sleep abnormality, but not depressive behaviors in olfactory bulbectomized rats.
Wang YQ; Tu ZC; Xu XY; Li R; Qu WM; Urade Y; Huang ZL
J Neurochem; 2012 Jan; 120(2):314-24. PubMed ID: 22035172
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats.
Nowak G; Szewczyk B; Wieronska JM; Branski P; Palucha A; Pilc A; Sadlik K; Piekoszewski W
Brain Res Bull; 2003 Jul; 61(2):159-64. PubMed ID: 12832002
[TBL] [Abstract][Full Text] [Related]
30. Quercetin suppress microglial neuroinflammatory response and induce antidepressent-like effect in olfactory bulbectomized rats.
Rinwa P; Kumar A
Neuroscience; 2013; 255():86-98. PubMed ID: 24095694
[TBL] [Abstract][Full Text] [Related]
31. Olfactory bulbectomy induces rapid and stable changes in basal and stress-induced locomotor activity, heart rate and body temperature responses in the home cage.
Vinkers CH; Breuer ME; Westphal KG; Korte SM; Oosting RS; Olivier B; Groenink L
Neuroscience; 2009 Mar; 159(1):39-46. PubMed ID: 19136045
[TBL] [Abstract][Full Text] [Related]
32. Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat.
Roche M; Harkin A; Kelly JP
Neuropsychopharmacology; 2007 Jun; 32(6):1312-20. PubMed ID: 17119540
[TBL] [Abstract][Full Text] [Related]
33. Antidepressants preferentially enhance habituation to novelty in the olfactory bulbectomized rat.
Mar A; Spreekmeester E; Rochford J
Psychopharmacology (Berl); 2000 May; 150(1):52-60. PubMed ID: 10867976
[TBL] [Abstract][Full Text] [Related]
34. S 47445 counteracts the behavioral manifestations and hippocampal neuroplasticity changes in bulbectomized mice.
Pilar-Cuellar F; Castro E; Bretin S; Mocaer E; Pazos Á; Díaz Á
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():205-213. PubMed ID: 30980840
[TBL] [Abstract][Full Text] [Related]
35. Galanin (1-15) Enhances the Behavioral Effects of Fluoxetine in the Olfactory Bulbectomy Rat, Suggesting a New Augmentation Strategy in Depression.
Flores-Burgess A; Millón C; Gago B; García-Durán L; Cantero-García N; Puigcerver A; Narváez JA; Fuxe K; Santín L; Díaz-Cabiale Z
Int J Neuropsychopharmacol; 2022 Apr; 25(4):307-318. PubMed ID: 34891163
[TBL] [Abstract][Full Text] [Related]
36. Delayed emergence of antidepressant efficacy following withdrawal in olfactory bulbectomized rats.
Noreika L; Pastor G; Liebman J
Pharmacol Biochem Behav; 1981 Sep; 15(3):393-8. PubMed ID: 7291242
[TBL] [Abstract][Full Text] [Related]
37. On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.
Pałucha-Poniewiera A; Wierońska JM; Brański P; Stachowicz K; Chaki S; Pilc A
Psychopharmacology (Berl); 2010 Dec; 212(4):523-35. PubMed ID: 20703449
[TBL] [Abstract][Full Text] [Related]
38. Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates.
Grecksch G; Zhou D; Franke C; Schröder U; Sabel B; Becker A; Huether G
Br J Pharmacol; 1997 Dec; 122(8):1725-31. PubMed ID: 9422820
[TBL] [Abstract][Full Text] [Related]
39. The olfactory bulbectomy model in mice and rat: one story or two tails?
Hendriksen H; Korte SM; Olivier B; Oosting RS
Eur J Pharmacol; 2015 Apr; 753():105-13. PubMed ID: 25446558
[TBL] [Abstract][Full Text] [Related]
40. Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study.
van der Stelt HM; Breuer ME; Olivier B; Westenberg HG
Biol Psychiatry; 2005 May; 57(9):1061-7. PubMed ID: 15860347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
